Mereo BioPharma (MREO) Current Taxes (2021)
Mereo BioPharma's (MREO) quarterly Current Taxes came in at $2.1 million in Q4 2021.
Powered by 
Analysis
Mereo BioPharma (MREO) Current Taxes (2021) Analysis & Trends
Mereo BioPharma (MREO) has reported Current Taxes for 1 consecutive years, with $2.1 million the latest figure, recorded in Q4 2021.
- On a quarterly basis, Current Taxes changed N/A year-over-year to $2.1 million in Q4 2021; TTM through Dec 2021 was $2.1 million, a N/A change from a year earlier, with the FY2021 full-year figure at $2.1 million, changed N/A from the prior year.
- Current Taxes was $2.1 million for Q4 2021 at Mereo BioPharma.
- Over five years, Current Taxes peaked at $2.1 million in Q4 2021 and troughed at $2.1 million in Q4 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 49.00 Mn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 86.90 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 74.18 Mn |
| 10 | Mereo BioPharma | 38.92 Mn | 38.92 Mn | - | - |